Friday, July 10, 2026

Drug profile · INN

tamoxifen

tamoxifen (GENOX 20) is a estrogen receptor alpha modulator. Associated with Alphapharm Pty Ltd.

TGA: approved NMPA: clinical trials
Patents linked 1
Pipeline programs 19
News articles 0
Drug details — tamoxifen

Quick answer

tamoxifen (GENOX 20) is a estrogen receptor alpha modulator. Associated with Alphapharm Pty Ltd.

Key facts

INN tamoxifen
Brand GENOX 20
Mechanism Estrogen receptor alpha modulator

Mechanism of action

Estrogen receptor alpha modulator

Approval history

Authority Status Date
TGA approved
NMPA clinical trials

Pipeline programs

  1. CTRIAL-IE 12-01 Phase 3 · Ningbo Cancer Hospital · Patients with 1-3 positive Nodes, Hormone Receptor-Positive
  2. GEICAM/2011-03_S1007 Phase 3 · Ningbo Cancer Hospital · patients with node positive breast cancer who do not have hi
  3. I3Y-MC-JPCF Phase 3 · Eli Lilly and · Breast Cancer
  4. MK-5684-015 Phase 3 · MSD Merck Sharp · Breast cancer, Ovarian cancer, Endometrial cancer
  5. STML-ELA-0422 Phase 3 · Stemline Therapeutics (United · Node-positive, Estrogen Receptor-positive, HER2-negative, Ea
  6. TAMOXIFEN for Breast cancer Phase 3 · Shanghai Zerun Biotechnology · Breast cancer
  7. Tamoxifen Phase 3 · International Peace Maternity · Breast Cancer
  8. Tamoxifen Phase 3 · Chinese Academy of · Breast Cancer Female
  1. US 7767717

    Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen

    Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is tamoxifen?

tamoxifen (GENOX 20) is a estrogen receptor alpha modulator. Associated with Alphapharm Pty Ltd.

What is the brand name for tamoxifen?

GENOX 20 is a marketed brand name for tamoxifen. Check FDA Drugs@FDA for the current US label holder and prescribing information.